Accessibility StatementSkip Navigation NEW YORK, Sept. 29, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of PubMatic, Inc. (NASDAQ: PUBM). Shareholders who purchased shares of PUBM during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/pubmatic-inc-loss-submission-form/?id=169607&fr ...

NEW YORK, Sept. 28, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of PubMatic, Inc. (NASDAQ: PUBM) between February 27, 2025 and August 11, 2025, both dates inclusive (the “Class Period”), of the important October 20, 2025 lead plaintiff deadline. SO WHAT: If you purchased PubMatic securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. ...

Accessibility StatementSkip Navigation LOS ANGELES, Sept. 26, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to PubMatic, Inc. ("PubMatic" or the "Company") (NASDAQ: PUBM) have opportunity to lead the securities fraud class action lawsuit. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN PUBMATIC, INC. (PUBM), CLICK HERE BEFORE OCTOBER 20, 2025 (THE LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT. What Is The Lawsuit About? ...

Accessibility StatementSkip Navigation https://zlk.com/pslra-1/pubmatic-inc-lawsuit-submission-form?prid=169364&wire=4 PUBM investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500. WHAT'S NEXT? If you suffered a loss in PubMatic, Inc. during the relevant time frame, you have until October 20, 2025 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. NO C ...

诉讼核心信息 - 针对PubMatic公司的联邦证券集体诉讼正在征集主要原告 截止日期为2025年10月20日 [1] - 诉讼代表在2025年2月27日至2025年8月11日期间购买该公司证券的投资者 [3] 股价影响事件 - 2025年8月11日盘后 PubMatic发布2025年第二季度财报 首席财务官透露公司前景反映了“来自一家顶级DSP合作伙伴的广告支出减少” [2] - 公司首席执行官进一步透露 一家“顶级DSP买家”已将“大量客户转移至一个采用不同库存评估方式的新平台” 这造成了显著的逆风 [2] - 在此消息影响下 PubMatic股价从2025年8月11日的每股10.57美元下跌2.23美元 跌幅约21.1% 至2025年8月12日收盘报每股8.34美元 [2] 诉讼指控内容 - 指控被告在诉讼期间做出了重大虚假和/或误导性陈述 且未披露有关公司业务、运营和前景的重大不利事实 [3] - 具体指控包括未向投资者披露：1）一家顶级DSP买家正将大量客户转移至采用不同库存评估方式的新平台；2）因此 PubMatic来自该顶级DSP买家的广告支出和收入正在减少；3）基于前述原因 被告关于公司业务、运营和前景的正面陈述存在重大误导且/或缺乏合理依据 [3]

NEW YORK, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in PubMatic, Inc. ("PubMatic, Inc." or the "Company") (NASDAQ: PUBM) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of PubMatic, Inc. investors who were adversely affected by alleged securities fraud between February 27, 2025 and August 11, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/pubmatic-inc ...

公司法律事件 - 公司PubMatic, Inc因涉嫌违反证券法而被起诉[1] - 投资者权利相关问题可联系DJS Law Group进行讨论[1]

Accessibility StatementSkip Navigation NEW YORK, Sept. 25, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of PubMatic, Inc. (NASDAQ: PUBM). Shareholders who purchased shares of PUBM during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/pubmatic-inc-loss-submission-form/?id=168870&fr ...

文章核心观点 - 律师事务所提醒投资者，针对PubMatic、Snap、Nutex Health和C3 ai四家上市公司已提起集体诉讼，指控公司在特定时期内发布了重大虚假和/或误导性陈述，未能披露对其业务、运营和前景不利的重大事实 [1][2][3][4][5][6] PubMatic公司诉讼要点 - 诉讼类别期从2025年2月27日持续至2025年8月11日，首席原告截止日期为2025年10月20日 [2] - 指控未能披露其顶级需求方平台买家正将大量客户转移至使用不同库存评估标准的新平台，导致来自该买家的广告支出和收入减少 [2] - 公司此前关于业务、运营和前景的正面陈述因此被指具有重大误导性和/或缺乏合理依据 [2] Snap公司诉讼要点 - 诉讼类别期从2025年4月29日持续至2025年8月5日，首席原告截止日期为2025年10月20日 [3] - 指控公司关于广告增长和盈利潜力的乐观报告脱离现实，过度依赖于其执行能力，且在公司声称因宏观经济状况缺乏可见性时，实际上已受到重大执行失误的影响 [3] - 公司关于业务、运营和前景的正面陈述因此被指在所有相关时间均具有重大误导性和/或缺乏合理依据 [3] Nutex Health公司诉讼要点 - 诉讼类别期从2024年8月8日持续至2025年8月14日，首席原告截止日期为2025年10月21日 [4] - 指控未能披露其合作伙伴HaloMD通过协同欺诈保险公司的计划获得仲裁收入，该部分收入不可持续，且公司对其财务报告内部控制重大弱点的补救程度或能力存在夸大 [4] - 指控公司未能有效核算某些股票薪酬义务，错误地将其计为权益而非负债，增加了无法及时向美国证券交易委员会提交财务报告的风险，导致其业务和/或财务前景被夸大 [4] C3 ai公司诉讼要点 - 诉讼类别期从2025年2月26日持续至2025年8月8日，首席原告截止日期为2025年10月21日 [5][6] - 指控公司关于增长、盈利潜力和预期利润率的乐观报告脱离现实，因其过度依赖于首席执行官的健康状况和效能，而首席执行官并未从其健康问题中充分恢复以履行原有职责 [6] - 公司关于业务、运营和前景的正面陈述因此被指在所有相关时间均具有重大误导性和/或缺乏合理依据 [6]

Accessibility StatementSkip Navigation Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In PubMatic To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in PubMatic between February 27, 2025 and August 11, 2025and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330Â (Ext. 1310). To learn more about the PubMatic class acti ...